In particular, Ueno et al. demonstrated that Wnt receptor frizzled-7 activates the Wnt/β-catenin pathway in colorectal cancer cells despite the presence of APC or CTNNB1 mutation and that frizzled-7-siRNA may be used as a therapeutic reagent for colorectal cancer [48]. Here, CTNNB1 is linked to colorectal cancer.